Investment
Features
FeesSafety
Academy
More
Pluang+

SoFi adds Pudgy Penguins' PENGU token to its app, boosting price 8.9%.

Market News
20 Oct 2026
Crypto Briefing
View Source
Bullish
SoFi adds Pudgy Penguins' PENGU token to its app, boosting price 8.9%.

SoFi, the first nationally chartered US bank to offer consumer crypto trading, added the PENGU token from the Pudgy Penguins NFT project to its banking app on October 19, 2026. This move allows SoFi's 15 million members to buy, sell, and hold PENGU directly within the app, increasing the token's accessibility beyond typical crypto exchanges. Following the listing, PENGU's price rose 8.9%, supported by a positive technical buy signal suggesting potential trend recovery. This listing highlights SoFi's willingness to embrace tokens from NFT projects, expanding crypto options in a regulated banking environment.

The SoFi addition of the PENGU token to its banking app provides context for crypto market activity. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 21, 2026 03:41 WIB: 45 of 50 major cryptocurrencies rose today. Notable movers include XTZ at Rp5.654 with a 4.65% increase and BAT at Rp3.601 with a 4.63% rise.

More News

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
47 minutes ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
1 hour ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
1 hour ago
CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

CMMB opens new Distribution Center at Brethren Service Center to boost global medicine access.

Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...

Others
Neutral
1 hour ago
Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Myriad Genetics upgraded to Neutral as it sells prenatal unit to Labcorp for $210M.

Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App